SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings of -$118.55M in Q1 FY2026
Q1 FY2026 retained earnings was -$118.55M.
Context
- Retained earnings amounted to 45.9% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (104.73M) USD
- Year-over-year change
- —
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (104.73M) | — |
Retained Earnings vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
- Retained earnings amounts to 45.9% of total assets for SGP, versus a peer median of 169.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $0 USD | — | — | 0.0% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | -$118.55M USD | — | — | 45.9% |
| Apr 2026 | -$142.82M USD | -17.3% | — | 31.7% | |
| Mar 2026 | -$397.7M USD | -10.3% | — | 362.5% | |
| Mar 2026 | -CHF 412.13M CHF | -29.3% | — | 169.4% | |
| Mar 2026 | -$676.92M USD | -7.4% | — | 222.7% | |
| Jun 2026 | -$971.29M USD | -24.0% | — | 105.5% | |
| Jun 2026 | -$1.02B USD | -20.2% | — | 7.3% | |
| Mar 2026 | -$1.19B USD | -29.6% | — | 412.8% | |
| Mar 2026 | -$1.25B USD | -30.4% | — | 170.0% | |
| Peer median (excluding SGP) | — | -22.1% | — | 169.4% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.